This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
August 31, 2020
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
August 31, 2020
Increase of number of shares and votes in Vicore Pharma
August 29, 2020
FDA grants Priority Review of melflufen for patients with triple-class refractory multiple myeloma
August 27, 2020
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2020
August 26, 2020
INTERIM REPORT Q2 2020
August 26, 2020
Interim report April-June 2020
August 25, 2020
CARISMA Therapeutics Enters Into Scientific Research and Licensing Agreement With NYU Langone Health, Gains Exclusive Rights to Vpx Lentiviral Vector
August 25, 2020
Vicore Pharma restarts mechanistic study with VP01 in systemic sclerosis
August 21, 2020
Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2020 Results Presentation and Webcast – correction
August 20, 2020
Targovax ASA: second quarter and first half 2020 results